FHD-609, an inhibitor and degrader of BRD9 (bromodomain-containing protein 9), targets the ncBAF complex and is useful for researching a broad spectrum of cancers with mutations in a BAF complex subunit. When used alongside Telomelysin or INO5401, FHD-609 could be effective in treating adrenocortical carcinoma (ACC).
Molecular Weight:
829
CAS Number:
[2676211-64-4]
Formula:
C47H56N8O6
Target:
Others,Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted
